$HMMJ.TO

Curaleaf Q1 2026 Net Revenue of US$324M; Net Income of $70M

High Tide Executes Term Sheet for $40 Million of Credit Facilities

High Tide (HITI.V, HITI) signed a term sheet with one of "Canada's Big 5 chartered banks" as its lender in respect of new senior secured credit facilities in the principal amount of $40 million, it said Tuesday.The new credit facilities will replace its existing senior credit facility with connectFirst Credit Union upon closing. The name of the lender will be disclosed at closing, expected within 60 days subject to satisfaction of customary conditions precedent, it said.The first committed facility is a $25 million committed revolver facility, to be used to refinance its loan with connectFirst at closing, general working capital or corporate needs, permitted acquisitions and permitted investments, and has a three-year maturity. The balance at connectFirst is expected to be a little over $6 million at closing, resulting in almost $19 million of available room on the revolver facility, the company said.The second committed facility is a $15 million committed delayed draw term loan to be used to refinance its existing $15 million second-lien debentures. High Tide can elect to draw on this facility at its option, and it will be repaid over a seven-year amortization period.U.S.-listed shares of the company were last seen down 0.8% at US$2.3997 in pre-market trading.

Trulieve Applies for U.S. DEA Registration Under New Cannabis Rules

Trulieve Cannabis (TRUL.CN) on Wednesday said it applied to the US Drug Enforcement Administration (DEA) to register some of its state-licensed medical-marijuana operations.The applications were filed under a new expedited process established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act, the company added.Under the new rules, eligible operators that apply within 60 days are automatically approved to manufacture, distribute, and sell these products unless the DEA says otherwise, according to the statement."With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis," Chief Executive Kim Rivers said.Price: $13.19, Change: $-0.50, Percent Change: -3.65%

Aurora Cannabis Launching New Medical Cannabis Products Globally

Aurora Cannabis (ACB.TO) is "significantly" expanding its global medical cannabis portfolio, with product launches rolling out across Canada, Europe and Australia, the company said on Tuesday.The newly expanded lineup includes dried flower, pre-rolls and pastilles, and will be rolled out between now and June, a statement added."By expanding our offerings in key countries, we're responding to clear patient and prescriber demand with products that meet local regulatory standards, offer meaningful choice across formats, and can be supplied reliably at scale - all while reinforcing the level of quality and trust expected from us," said Lana Culley, who heads innovation and international operations at Aurora.Aurora shares were last seen down US$0.08, to US$3.43 in U.S. pre-market trading.

TerrAscend Announces Preliminary First Quarter 2026 Financial Results

TerrAscend (TSND.TO), a North American cannabis operator, announced preliminary and unaudited financial results for the first quarter ended March 31, 2026, on Monday.The preliminary and unaudited financial results reported are from continuing operations, and do not include Michigan, which are reported as discontinued operations effective as of the second quarter ended June 30, 2025, said the company.For the first quarter of 2026, the company expects net revenue of US$65.5 million, compared to US$66.1 million in the fourth quarter of 2025 and US$64.3 million in the first quarter of 2025.It expects gross profit margin of 52.8% for the first quarter of 2026, compared to 52.1% in the fourth quarter of 2025 and 53.9% in the first quarter of 2025.The company's shares were last seen up C$0.03 or 3.3% at C$0.94 on the Toronto Stock Exchange.Price: $0.95, Change: $+0.04, Percent Change: +4.40%

TSX Closer: Index Down As News of U.S. Reclassification Fails To Keep Fire Burning Under Cannabis Stocks

The Toronto Stock Exchange edged lower on Thursday as news of the U.S. reclassification of cannabis initially lit up cannabis stocks, but failed to keep a fire burning as investors realized full legalization of the sector will require further legislative action.The S&P/TSX Composite Index closed down 42.18 points to 33,912.93, only its fourth loss in 17 sessions, as investors also took profits after a recent run of winning days, while geopolitical tensions and uncertainty around the Iran war continue to cast a shadow over the outlook for markets.Sectors were mixed, but the two biggest movers were Health Care, down 7.7% and Info Tech, down 4.5%. The Battery Metals Index was up 4%.Within the health sector, cannabis firms lost early gains Thursday as investors at first welcomed news the Department of Justice was "immediately rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule III", but after some more inspection seemed to conclude the move fell short of full legalization.Aurora Cannabis (ACB.TO) was down 14%, Canopy Growth (WEED.TO) fell 13%, Cronos Group (CRON.TO) was down 8% and Tilray Brands (TLRY.TO) lost 13%.BNN Bloomberg spoke with Pablo Zuanic, managing partner at Zuanic & Associates, about the implications for cannabis companies, investors and the broader industry. Among key takeaways, BNN noted the change reduces tax burdens by allowing companies to deduct operating expenses, improving cash flow, while expanded research and federal registration for operators are expected to support industry development. But, BNN also noted, cannabis remains federally illegal, and interstate trade and exports are still restricted. The move is seen as a step toward broader reform, but full legalization would require further legislative action.Of commodities, the Energy sector was up near 1.8% as West Texas Intermediate crude oil closed higher with the United States and Iran making little progress to end a war that has produced the largest-ever supply shock with shipments from the Persian Gulf region barred from the Strait of Hormuz. WTI crude oil for June delivery closed up US$2.89 to settle at US$95.85 per barrel, while June Brent oil was up US$3.07 to US$104.98.Base Metals lost near 3.2% as gold fell, remaining rangebound amid concerns high oil prices will push up inflation and force hikes to interest rates. Gold for June delivery was down US$34.00 to US$4,719.00 per ounce.

Tilray Up 14% In US Premarket Trade As Says "Positioned" For Expansion "Amid Historic Cannabis Rescheduling"

Tilray Brands (NASDAQ and TSX: TLRY) is "positioned" for expansion in the United States as federal policy there has opened the door to rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, the company said Thursday,Shares in Tilray, a player in the cannabis, beverage, and wellness industries, were at at last look up more than 12% in US premarket trade on what the company called "an inflection point". They rose more than 14% in the US yesterday."A defining inflection point that represents a fundamental shift in U.S. drug policy, unlocking significant opportunities for medical cannabis clinical research, patient access, and industry standardization. The action represents the most consequential federal cannabis policy development in decades, accelerating the emergence of a regulated, science-driven medical cannabis framework in the United States," Tilray in a statement.Rescheduling has the potential to accelerate clinical research, broaden access, and "elevate the quality, consistency, and safety standards that establish medical cannabis as a legitimate pillar of modern healthcare", added Irwin D. Simon, Chairman and Chief Executive Officer.

Tilray Brands Adds Tilray Medical "Poised To Accelerate U.S. Medical Cannabis Access For Patients"

Tilray Brands Says "Positioned For U.S. Expansion Amid Historic Cannabis Rescheduling"

Green Thumb Industries' Board Authorizes Additional US$100M for Share Repurchase Program

Green Thumb Industries' (GTII.CN), a national cannabis consumer packaged goods company that saw its shares rise 11% yesterday, authorized an additional US$100 million for its existing share buy-back program announced on September 16, 2025, it said Thursday.The buy-back program now authorizes the repurchase of its subordinate voting shares having an aggregate value of up to $150 million, it added.Approximately 7.5 million shares for approximately $43.4 million have been repurchased since the program began on September 23, 2025, GTII said. Of that total, approximately 6.0 million shares for approximately $33.0 million were repurchased in the first quarter of 2026, it added."We have built a strong business, and we do not believe our current share price fully reflects that value. We have demonstrated our conviction in Green Thumb through meaningful share repurchases, and this added capacity gives us greater flexibility to continue deploying capital opportunistically," said Green Thumb Founder, Chairman and CEO Ben Kovler.The existing repurchase program will expire on September 22, 2026.Shares closed up 11% to $10.81 on Wednesday on the Canadian Securities Exchange.

Green Thumb Industries Announces an Additional $100M Authorized for its Share Repurchase Program

High Tide Announcing "Proactive Steps to Investigate and Address Potential Manipulation of Its Common Shares"

TSX Closer: The Index Recovers From Tuesday's Slump, Boosted By Higher Commodity Prices and Cannabis Stocks

The Toronto Stock Exchange on Wednesday recovered from its day-prior slump, boosted by cannabis stocks and higher commodity prices, even as National Bank said the positive impact of commodities on the real economy is expected to be limited.The resources-heavy S&P/TSX Composite Index closed up 146.81 points, or 0.4%, to 33,955.11, after losing near 550 points on Tuesday, only its third loss in the last 16 sessions.Most sectors were higher, led by Health Care, up 6.6%, amid reports the U.S. Justice Department will ease restrictions around the cannabis market this week. Among individual related stocks, Curaleaf (CURA.TO) jumped 25%.Among other sectors, Base Metals was up 3.7% and Telecom up 2.75%. The Battery Metals Index was down 5.8%.National Bank published its Monthly Economic Monitor on Economics and Strategy report entitled 'Can the commodities boom revitalize the economy?'. National Bank noted the commodity price surge is bolstering terms of trade, public finances, and corporate profits in Canada's resource sector. "But its positive impact on the real economy is expected to be limited, it said, before adding: "Despite a sharp rise in energy and commodity prices, the resource sector, which is not labour-intensive and faces a lack of incentives to invest, is unlikely to generate many jobs, while weakness persists in other sectors, including manufacturing."At the same time, the bank said, consumers face several headwinds, including inflation that is set to rise temporarily and a downturn in the housing market is exacerbated by population decline, which is resulting in a negative wealth effect.The bank added: "The slowdown in immigration is limiting economic growth in 2026, which is expected to come in at 1.0%, a pace sufficient for the labour market to improve somewhat by the end of the year. A relatively smooth renegotiation of CUSMA is necessary for such an improvement to materialize."Of commodities today, West Texas Intermediate crude oil rose after the United States extended a ceasefire with Iran while continuing to blockade the country's ports, and as Iran attacked ships in the Persian Gulf while rejecting talks with the U.S. until the blockade is lifted. WTI crude oil for June delivery closed up US$3.29 to settle at US$92.96 per barrel, while June Brent oil was last seen up US$3.65 to US$102.13.Gold traded higher on Wednesday following two losing sessions after the United States extended a ceasefire related to its war on Iran. Gold for June delivery was up US$35.70 to US$4,755.30 per ounce.

High Tide Opening New Canna Cabana in Caledonia, Ontario

Cannabis retailer High Tide (HITI.V, Nasdaq: HITI) said Monday that it is opening a new retail cannabis store in Caledonia, Ontario.The company will begin selling recreational cannabis products along with related accessories for adult use on April 20. This opening brings High Tide's total store count to 221 Canna Cabana locations across the country, and 97 in Ontario."Opening on 4/20 is always symbolic, but this year is especially meaningful as we approach eight years since launching our very first Canna Cabana store in October 2018," said Raj Grover, founder and chief executive officer.High Tide shares closed down $0.04, to $3.28, on Friday, on the TSX Venture Exchange.

iAnthus Capital Holdings Expands Florida Footprint

iAnthus Capital Holdings (IAN.CN) on Friday announced the opening of its dispensary location in Tequesta-Jupiter, Florida, marking its 26th dispensary in Florida.The company said that the dispensary began serving patients on April 14, 2026 and expands access to iAnthus' portfolio of "premium cannabis products", including The Vault, Sunshine State, and MPX."Our GrowHealthy dispensary in Tequesta-Jupiter expands access for patients across a region that has had limited nearby options," said Kelly Heinichen, Vice President of Retail Operations for iAnthus. "We're focused on a seamless experience for the patients of Palm Beach County: fast service, knowledgeable teams, and best-in-class flower genetics."Shares of the company were last seen unchanged at $0.005 on the Canadian Securities Exchange.

PharmaCielo Intends to Issue 11.1-Million Interest Shares

PharmaCielo (PCLO.V) on Friday said it intends to issue more than 11.1-million of its common shares at $0.08 apiece, in satisfaction of an aggregate of $891,681.85 in accrued semi-annual interest payments due to holders of the company's 11% secured debentures, subject to the approval of the TSX Venture Exchange (TSXV).PharmaCielo is the Canadian parent of Colombia cultivator and producer of dried flower and food and medicinal grade cannabis extracts for the natural pharmaceuticals and consumer products market, PharmaCielo Colombia Holdings S.A.S.Shares of the company closed unchanged at $0.045 on Thursday on the TSXV.

Trulieve Cannabis Opening New Dispensary in Tallahassee, Florida

Trulieve Cannabis (TRUL.CN) said Friday that its new medical cannabis dispensary in Tallahassee, Florida, will have a "grand" opening on April 20.The new dispensary will carry a wide variety of popular products including Trulieve's portfolio of in-house brands and partner brands."We are thrilled to open our third location in our home town of Tallahassee," said Trulieve's chief executive Kim Rivers. "Our team is excited to serve patients with high-quality products and exceptional experiences."TRUL will hold a conference call on Thursday, May 7, 2026 at 8:30 AM Eastern Time following the release of its first quarter 2026 financial results.Trulieve closed down $0.30, to $8.95 on Thursday, on the Canadian Securities Exchange.

TerrAscend Appoints Eric Jackson as Chief Financial Officer

TerrAscend (TSND.TO), a North American cannabis operator, after trade Thursday said it appointed Eric Jackson as chief financial officer, effective April 27.According to a statement, Jackson brings more than two decades of finance and operational leadership experience across retail, consumer, and manufacturing sectors. Most recently, he served for over eight years as Chief Financial Officer of American Signature, Inc., a multi-location, omnichannel retailer where he oversaw finance, accounting, treasury, analytics, IT, real estate, and supply-chain functions.Prior to American Signature, Jackson spent more than 14 years at L Brands, a publicly traded specialty retailer whose portfolio included Victoria's Secret, PINK, Bath & Body Works, La Senza, and Henri Bendel.TerrAscend shares closed down $0.06 to $0.91 on the Toronto Stock Exchange.

LEEF Brands Climbs On HIMALAYA

Cannabis company LEEF Brands (LEEF.CN) on Thursday said it entered into an agreement to acquire Standard Holdings, Inc., the parent company of HIMALAYA VAPOR, a California-based cannabis concentrates brand."The acquisition strengthens LEEF's vertical integration strategy by pairing one of California's most efficient cultivation and extraction platforms with a top-tier consumer brand," said the company.LEEF said it will acquire HIMALAYA for around 13.688 million common shares of the company, which includes management incentive shares, and will issue warrants with an aggregate value of US$100,000 priced at C$0.25 per share, representing total consideration of approximately US$2.5 million.It added that, by integrating HIMALAYA into its platform, LEEF expects to immediately improve unit economics by lowering input costs and generate "meaningful" free cash flow from HIMALAYA during its first year of combined operations.Micah Anderson, Chief Executive Officer of LEEF Brands, said: "This is exactly the type of acquisition we are focused on: a premium, authentic brand with strong customer loyalty that we can scale more efficiently through our vertically integrated infrastructure. Having worked with the HIMALAYA team for over five years, we have strong conviction in both the brand and its leadership, which further reinforces our confidence in this partnership. By leveraging low-cost inputs from Salisbury Canyon Ranch, we believe we can significantly improve margins while expanding distribution across California and into new markets over time."Price: $0.22, Change: $+0.01, Percent Change: +4.88%

Tilray Files ATM Program to Accelerate Global Beverage Expansion As It Outlines Strategic Initiatives For Growth

Tilray Brands (TLRY.TO) Wednesday highlighted a series of strategic initiatives, expected to mark its next phase of growth, and they included advancing its UK healthcare platform with the Lyphe acquisition, positioning BrewDog in the beverages market, and preparing for a U.S. rescheduling and medical cannabis opportunityTilray said it had acquired the Lyphe Group, a UK-based medical cannabis clinic and digital pharmacy platform, with Lyphe Dispensary having dispensed approximately 150,000 units to date and Lyphe Clinic having treated over 16,000 patients to date. A deal "anchoring and expanding" Tilray Medical's footprint in "one of Europe's largest and most dynamic healthcare markets", it said.Six weeks following Tilray's acquisition of BrewDog, the company said it has "stabilized brewing volumes, maintained service levels across channels to ensure consistent stock availability, and has begun onboarding new distribution and strategic partners to support expansion". It is also evaluating its participation in the Center for Medicare and Medicaid Innovation pilot program.To support this next phase of growth, Tilray also announced the filing of an at-the-market equity program of up to US$180 million, "to enhance financial flexibility and to invest behind its global beverage platform."Tilray Brands chief financial officer Carl Merton said: "We remain focused on disciplined capital allocation, prioritizing investments that support our long-term growth strategy while maintaining a strong balance sheet. This structure allows us to align capital deployment with evolving market conditions and our operational priorities."Tilray shares were last seen down US$0.05, to US$6.86, in U.S. pre-market trading.